Pfiz­er mulls fa­cil­i­ty sale; GSK pe­nal­ized in South Ko­rea for ad­min­is­tra­tive breach

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Pfiz­er is con­sid­er­ing sell­ing a fa­cil­i­ty …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER